Shopping Cart
Remove All
Your shopping cart is currently empty
Temelimab (GNbAC-1) is a monoclonal antibody targeting endogenous retroviruses in humans, used for studying multiple sclerosis (MS) and type 1 diabetes (T1D).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $486 | In Stock | In Stock | |
| 5 mg | $1,350 | In Stock | In Stock | |
| 10 mg | $1,830 | - | In Stock | |
| 25 mg | $2,690 | - | In Stock |
| Description | Temelimab (GNbAC-1) is a monoclonal antibody targeting endogenous retroviruses in humans, used for studying multiple sclerosis (MS) and type 1 diabetes (T1D). |
| In vitro | Temelimab was well tolerated and safe in vivo. [1] |
| In vivo | No effects on clinical signs, body weight, food consumption, or pathology were observed in Temelimab (6 mg/kg and 30 mg/kg intravenously) mice. [1] |
| Synonyms | GNN-001, GNN001, GNbAC-1, GNbAC1, GENHP-01, GENHP01 |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 1393641-34-3 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.